TITLE

Drug Roundup

PUB. DATE
May 2004
SOURCE
RN;May2004, Vol. 67 Issue 5, p85
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents news concerning drug development in the United States as of May 2004. Cases of oligohidrosis and hyperthermia reported in patients taking topiramate tablets or sprinkle capsules; Food and Drug Administration's investigation of reports that unlicensed flu vaccine is being sold in the country.
ACCESSION #
13403176

 

Related Articles

  • Quadrivalent flu vaccine discussed. Blazek, Nicole // Infectious Diseases in Children;Mar2009, Vol. 22 Issue 3, p20 

    The article reports that U.S. health officials who attended the meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) have discussed the possibility of developing a quadrivalent influenza vaccine that would extend protection against the Victoria and Yamagata...

  • Universal flu vaccine? Kåhrström, Christina Tobin // Nature Reviews Microbiology;Nov2013, Vol. 11 Issue 11, p740 

    The article reports on a research finding which indicates that the use of virus-specific CD8+T cells in targeting conserved core proteins could be a blueprint for a universal flu vaccine.

  • Liposomal Influenza Vaccine. Holm, K.J.; Goa, K.L. // BioDrugs;1999, Vol. 11 Issue 2, p137 

    ▴ This trivalent liposomal influenza vaccine consists of purified influenza haemagglutinin inserted into a membrane of phosphatidylcholine and phosphatidylethanolamine. It contains 15µg of haemagglutinin per viral strain per dose. ▴ The vaccine is immunogenic in the elderly, in...

  • Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9). Osterholm, Michael T.; Ballering, Katie S.; Kelley, Nicholas S. // JAMA: Journal of the American Medical Association;6/26/2013, Vol. 309 Issue 24, p2557 

    The authors discuss the need for influenza vaccine specialists to advance with the development of novel antigen influenza vaccines in light of the emergence of avian influenza A (H7N9) virus infections in humans. They describe primary scenarios for how the virus outbreak will unfold. Ways to...

  • New type of flu vaccine is quicker to produce.  // Modern Healthcare;11/26/2012, Vol. 42 Issue 48, p4 

    The article announces the approval of a new seasonal influenza vaccine called FluceIvax produced by Novartis Vaccines and Diagnostics by the U.S. Food and Drug Administration (FDA).

  • Safety labeling updates & new warnings.  // Formulary;Feb2004, Vol. 39 Issue 2, p90 

    Presents labeling updates and medication advisory as of February 2004. Issuance of revised labeling for topiramate; Advisory on oseltamivir administration to children aged less than 1 year; Modification of pergolide labeling.

  • A very large diversity space of synthetically accessible compounds for use with drug design programs. Nikitin, Sergey; Zaitseva, Natalia; Demina, Olga; Solovieva, Vera; Mazin, Evgeny; Mikhalev, Sergey; Smolov, Maxim; Rubinov, Anatoly; Vlasov, Peter; Lepikhin, Dmitry; Khachko, Denis; Fokin, Valery; Queen, Cary; Zosimov, Viktor // Journal of Computer-Aided Molecular Design;Jan2005, Vol. 19 Issue 1, p47 

    We have constructed a very large virtual diversity space containing more than 1013 chemical compounds. The diversity space is built from about 400 combinatorial libraries, which have been expanded by choosing sizeable collections of suitable R-groups that can be attached to each link point of...

  • Pediatric Drug Development. Rose, Klaus // Applied Clinical Trials;Jan2005, Vol. 14 Issue 1, p50 

    Discusses issues related to pediatric drug development. Improvement in pharmaceutical treatment of treatment; Progress in drug discovery and clinical drug development; Integration of pediatric assessments into the general drug development process.

  • Welcome to Pharmaceutical Methods. Furey, Ambrose // Pharmaceutical Methods;Oct2010, Vol. 1 Issue 1, p1 

    The author looks at the complexity of drug development as one aspect of a pharmaceutical endeavour. He explores the steps in identifying a potential drug which include the process of chemical characterization of the molecule. He argues that animal models cannot be assumed to be absolute...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics